Glioblastomas

A first-in-human clinical trial will assess the safety of a personalized vaccine to treat diffuse hemispheric glioma, an aggressive brain tumor.

Compared with gross total resection, lobectomy as a surgical intervention for individuals with glioblastoma had a more positive impact on progression-free and overall survival outcomes, according to a systematic review and meta-analysis.